Lesudac 25 Tablet contains Levosulpiride 25 mg, a selective dopamine D2 receptor antagonist primarily used for the treatment of gastrointestinal motility disorders and psychiatric conditions. It exerts prokinetic effects by enhancing gastric emptying and improving esophageal motility, making it effective in managing symptoms associated with functional dyspepsia, gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS). Additionally, Levosulpiride has antipsychotic and antidepressant properties due to its action on central dopaminergic pathways, which can be beneficial in treating schizophrenia, depression, and anxiety disorders. Lesudac 25 is typically prescribed to alleviate nausea, vomiting, bloating, and abdominal discomfort, as well as to improve mood and cognitive functions in certain psychiatric conditions. The medication is generally well-tolerated; however, it may cause side effects such as drowsiness, dizziness, extrapyramidal symptoms, or hyperprolactinemia in some patients. It is contraindicated in individuals with hypersensitivity to sulpiride or other benzamide derivatives, and caution is advised in patients with renal or hepatic impairment. Lesudac 25 should be used under medical supervision, adhering to prescribed dosages to minimize adverse effects and ensure therapeutic efficacy.